SCHEMBL7387402

SCHEMBL7387402

[CH2]c1cccc(OCCOCC)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.47
HTT P42858 1/20 0.47
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
TAAR1 Q96RJ0 1/20 0.46
NCF1 P14598 2/20 0.45
LMNA P02545 2/20 0.43
TSHR P16473 1/20 0.43
MAPT P10636 1/20 0.43
ALDH1A1 P00352 1/20 0.43
MAPK1 P28482 5/20 0.42
TDP1 Q9NUW8 1/20 0.42
TP53 P04637 1/20 0.42
CYP3A4 P08684 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.41
APP P05067 1/20 0.41
EPHX2 P34913 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C19 P33261 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15219217 0.87 KDM4E (0.57) KDM4EHTTMEN1KMT2ATAAR1
SCHEMBL16667635 0.85 KDM4E (0.59) KDM4EHTTMEN1KMT2ATAAR1
SCHEMBL16669059 0.85 KDM4E (0.59) KDM4EHTTMEN1KMT2ATAAR1
SCHEMBL3469900 0.84 TSHR (0.46) KDM4EHTTLMNATSHRMAPT
SCHEMBL3470996 0.84 TSHR (0.46) KDM4EHTTLMNATSHRMAPT
SCHEMBL3470603 0.84 TSHR (0.46) KDM4EHTTLMNATSHRMAPT
SCHEMBL910975 0.83 KMT2A (0.54) KDM4EMEN1KMT2ALMNATSHR
SCHEMBL129082 0.83 TP53 (0.59) KDM4EHTTMEN1KMT2ALMNA
SCHEMBL3469884 0.81 MAPK1 (0.46) KDM4ETSHRALDH1A1MAPK1CYP1A2
SCHEMBL3210462 0.81 TSHR (0.54) KMT2ATSHRCYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6420418-B1 INHIBITION AND PREVENTION OF LEUKOCYTE ADHESION; USED TO TREAT ADHESION-MEDIATED DISEASES SUCH AS ASTHMA, ALLERGIC RHINITIS, MULTIPLE SCLEROSIS; ATHEROSCLEROSIS, AND INFLAMMATORY BOWEL DISEASE MERCK & CO., INC. 2002-07-16 US disclosed
WO-2001012183-A1 HETEROCYCLE AMIDES AS CELL ADHESION INHIBITORS MERCK & CO., INC. (US) 2001-02-22 WO disclosed